988 related articles for article (PubMed ID: 12136475)
1. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
3. [Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors].
Shilov EM; Tareeva IE; Ivanov AA; Lavrova ON; Krasnova TN; Khudova IIu; Miroshnichenko NG; Ratner MIa; Biriukova LS
Ter Arkh; 2000; 72(6):21-5. PubMed ID: 10900643
[TBL] [Abstract][Full Text] [Related]
4. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
6. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
7. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
8. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
10. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K; Yamamoto A; Ogawa N; Sekine T; Tamai S; Motoyama O
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[TBL] [Abstract][Full Text] [Related]
11. [The immunohistochemical heterogeneity of mesangioproliferative glomerulonephritis].
Varshavskiĭ VA; Gasanov AB
Arkh Patol; 1990; 52(8):33-7. PubMed ID: 1704206
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
13. [Mesangioproliferative glomerulonephritis with IgM deposits as an independent form of nephritis].
Serov VV; Varshavskiĭ VA; Gasanov AB
Arkh Patol; 1990; 52(2):19-23. PubMed ID: 2191638
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
15. Studies on circulating immune complexes. II: Circulating immune complexes in primary IgA nephropathy and membranoproliferative glomerulonephritis.
Miura Y
Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):193-200. PubMed ID: 2739118
[TBL] [Abstract][Full Text] [Related]
16. [Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis].
Ivanova LV; Shilov EM; Ivanov AA; Kozlovskaia LV; Rudolph P; Proppe D
Ter Arkh; 2003; 75(6):11-7. PubMed ID: 12920952
[TBL] [Abstract][Full Text] [Related]
17. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological correlation of young onset chronic glomerulonephritis].
Naito S; Kitagawa T
Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):275-86. PubMed ID: 2739125
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis of chronic glomerulonephritis--study on renal survival ratio of mesangial proliferative glomerulonephritis and membranoproliferative glomerulonephritis].
Saito T; Sato H; Kinoshita Y; Seino J; Furuyama T; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):959-65. PubMed ID: 2263026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
